TCM Ltd Announces AGM and Releases Annual Report for FY 2024-2025 with Highlight on Fluorecare MF-01 Diagnostic Platform

TCM Ltd, formerly known as Travancore Chemical & Mfg Co.Ltd., has announced the Notice of the Annual General Meeting (AGM) to be held on Saturday, 27th September 2025. The announcement came along with the release of the Annual Report for the Financial Year 2024-2025, as required under Regulation 34 of the SEBI (LODR) Regulations, 2015. The report includes the company's performance, financial statements, and other statutory information. A significant highlight from the report is the introduction of the Fluorecare MF-01 Fluorecare Immunofluorascence Quantitative Platform, a diagnostic tool that uses immunechromatography technology for the diagnosis of common human diseases. The platform measures the concentration of various biological markers including tumor markers, hormone markers, infection markers, cardiac markers, and diabetes markers with excellent accuracy and easy operation.